Antisense oligonucleotides as emerging drugs

By Nyce J.W.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Antisense Oligonucleotides for the Treatment of Dyslipidemia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 950-960

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

By Maksimenko Andrei   Malvy Claude  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 825-830

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

By Henry S.P.   Danis R.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 2, 2001-02 ,pp. : 277-291

Informa Healthcare

Access to resources Recommend Favorite

Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases

By  

Current Drug Targets, Vol. 6, Iss. 1, 2005-02 ,pp. : 21-29

Bentham Science Publishers

Access to resources Recommend Favorite